Shiraz E-Medical Journal

Published by: Kowsar

Quality of Life of Migraine Patients Treated With Combined Propranolol and Topiramate

Sulmaz Ghahramani 1 , Negin Hadi 2 , * , Abdolhamid Shariat 3 , Zahra Memar 4 and Ali Montazeri 5
Authors Information
1 Department of Community Medicine, Shiraz University of Medical Sciences, Shiraz, IR Iran
2 Neurosciences Research Center, Research Center for Psychiatry and Behavioral Sciences, Department of Community Medicine, Shiraz University of Medical Sciences, Shiraz, IR Iran
3 Department of Neurology, Shiraz University of Medical Sciences, Shiraz, IR Iran
4 Shiraz Medical School, Shiraz University of Medical Sciences, Shiraz, IR Iran
5 Health Metrics Research Center, Department of Mental Health Research, Iranian Institute for Health Sciences Research, Tehran, IR Iran
Article information
  • Shiraz E-Medical Journal: November 01, 2014, 15 (4); e23277
  • Published Online: November 22, 2014
  • Article Type: Research Article
  • Received: September 6, 2014
  • Accepted: September 7, 2014
  • DOI: 10.17795/semj23277

To Cite: Ghahramani S, Hadi N, Shariat A, Memar Z, Montazeri A. Quality of Life of Migraine Patients Treated With Combined Propranolol and Topiramate, Shiraz E-Med J. 2014 ; 15(4):e23277. doi: 10.17795/semj23277.

Copyright © 2014, Shiraz University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. De Santé HA. Diagnostic and therapeutic management of migraine in adults and children: clinical and economical aspects. 2002;
  • 2. Haut SR, Bigal ME, Lipton RB. Chronic disorders with episodic manifestations: focus on epilepsy and migraine. Lancet Neurol. 2006; 5(2): 148-57[DOI][PubMed]
  • 3. Schurks M, Rist PM, Bigal ME, Buring JE, Lipton RB, Kurth T. Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ. 2009; 339[DOI][PubMed]
  • 4. Chaushev N, Milanov I. Impact of migraine and migraine treatment on patient's capacity to work and quality of life. J Clin Med. 2009; 2(3): 26-31
  • 5. Burton WN, Landy SH, Downs KE, Runken MC. The impact of migraine and the effect of migraine treatment on workplace productivity in the United States and suggestions for future research. Mayo Clin Proc. 2009; 84(5): 436-45[DOI][PubMed]
  • 6. Stokes M, Becker WJ, Lipton RB, Sullivan SD, Wilcox TK, Wells L, et al. Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS). Headache. 2011; 51(7): 1058-77[DOI][PubMed]
  • 7. Garza I, Swanson JW. Prophylaxis of migraine. Neuropsychiatr Dis Treat. 2006; 2(3): 281-91[PubMed]
  • 8. Hankey Gj, Wardlaw JM. Clinical neurology. 2008; [DOI]
  • 9. Pompili M, Serafini G, Innamorati M, Serra G, Dominici G, Fortes-Lindau J, et al. Patient outcome in migraine prophylaxis: the role of psychopharmacological agents. Patient Relat Outcome Meas. 2010; 1: 107-18[DOI][PubMed]
  • 10. Nunnally JC. Psychometric Theory. 2010;
  • 11. Lipton RB, Liberman JN, Kolodner KB, Bigal ME, Dowson A, Stewart WF. Migraine headache disability and health-related quality-of-life: a population-based case-control study from England. Cephalalgia. 2003; 23(6): 441-50[PubMed]
  • 12. Lanteri-Minet M, Radat F, Chautard MH, Lucas C. Anxiety and depression associated with migraine: influence on migraine subjects' disability and quality of life, and acute migraine management. Pain. 2005; 118(3): 319-26[DOI][PubMed]
  • 13. Silberstein S, Lipton R, Dodick D, Freitag F, Mathew N, Brandes J, et al. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures. Headache. 2009; 49(8): 1153-62[DOI][PubMed]
  • 14. Holroyd KA, Cottrell CK, O'Donnell FJ, Cordingley GE, Drew JB, Carlson BW, et al. Effect of preventive (beta blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: randomised controlled trial. BMJ. 2010; 341[DOI][PubMed]
  • 15. Silberstein SD, Dodick DW, Lindblad AS, Holroyd K, Harrington M, Mathew NT, et al. Randomized, placebo-controlled trial of propranolol added to topiramate in chronic migraine. Neurology. 2012; 78(13): 976-84[DOI][PubMed]
  • 16. Domingues RB, Silva AL, Domingues SA, Aquino CC, Kuster GW. A double-blind randomized controlled trial of low doses of propranolol, nortriptyline, and the combination of propranolol and nortriptyline for the preventive treatment of migraine. Arq Neuropsiquiatr. 2009; 67(4): 973-7[PubMed]
  • 17. Brandes JL, Saper JR, Diamond M, Couch JR, Lewis DW, Schmitt J, et al. Topiramate for migraine prevention: a randomized controlled trial. JAMA. 2004; 291(8): 965-73[DOI][PubMed]
  • 18. Montazeri A, Goshtasebi A, Vahdaninia M, Gandek B. The Short Form Health Survey (SF-36): translation and validation study of the Iranian version. Qual Life Res. 2005; 14(3): 875-82[PubMed]
  • 19. Dodick DW, Silberstein S, Saper J, Freitag FG, Cady RK, Rapoport AM, et al. The impact of topiramate on health-related quality of life indicators in chronic migraine. Headache. 2007; 47(10): 1398-408[DOI][PubMed]
  • 20. Brandes JL, Kudrow DB, Rothrock JF, Rupnow MF, Fairclough DL, Greenberg SJ. Assessing the ability of topiramate to improve the daily activities of patients with migraine. Mayo Clin Proc. 2006; 81(10): 1311-9[DOI][PubMed]
  • 21. Brandes JL. The influence of estrogen on migraine: a systematic review. JAMA. 2006; 295(15): 1824-30[DOI][PubMed]
  • 22. Fillingim RB. Sex, gender, and pain: women and men really are different. Curr Rev Pain. 2000; 4(1): 24-30[PubMed]
  • 23. Raggi A, Giovannetti AM, Quintas R, D'Amico D, Cieza A, Sabariego C, et al. A systematic review of the psychosocial difficulties relevant to patients with migraine. J Headache Pain. 2012; 13(8): 595-606[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments